Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 236 results for "ranbaxy laboratories"

Top Pharma news of the day
India Infoline

Ranbaxy hunting ground for poachers post buyout by Sun

MUMBAI: Sun Pharmaceutical's $3.2-billion acquisition of Ranbaxy Laboratories, which has made it the nation's largest drug maker, has opened an exit door for many employees and a hiring ground for rivals. According to company sources, former employees at ... Economic Times, 1 day ago
Top Pharma news of the day India Infoline, 1 week ago

Opening Bell | DLF, Jet Airways, ONGC, Oil India in focus

Asian markets in the green Asian markets were trading higher on Thursday morning, following firm global cues. Japan's Nikkei Stock Average was up 1% after services purchase manager's index climbed to a two-year high. Chinese and Hong Kong ...
 Livemint.com1 day ago Fifteen stocks in focus in Tuesday morning trade  Economic Times1 month ago Opening Bell | Infosys, Sun Pharma, Bharti Airtel in focus  Livemint.com1 month ago

Sun Pharma gets FDA approval for acne treatment

Sun Pharma HQ The FDA has approved Sun Pharma's new acne treatment, Ximino. The Ximino (minocycline hydrochloride) extended-release capsules, which will be available in 45 mg, 90 mg and 135 mg dosages, are available for inflammatory lesions of ...
 Pharmafile1 week ago
Nikkei Asian Review

Sun may only get 3 of Ranbaxy's 4 banned plants ready for U.S. market

Ranbaxy Laboratories, which Sun Pharmaceutical recently acquired for $4 billion, has four plants in India that once produced products for the U.S. market. All four were banned by the FDA over the last 5 years for manufacturing and drug testing ...
 FiercePharmaManufacturing1 month ago Triage the plan as India's Sun moves on troubled Ranbaxy plants  Fierce Biotech IT1 month ago Ranbaxy a bitter pill for Sun Pharma  Nikkei Asian Review1 week ago India : CERTAIN non-strategic businesses of Ranbaxy to be discontinue by Sun Pharmaceutical [TendersInfo (India)]  Pharmacy Choice1 month ago
Hindustan Times

Sun Pharma slumps after Q1 net profit falls

A drop in US sales and the integration of Ranbaxy Laboratories weighed on its financial performance. The nation's top drug maker took a Rs 685 crore charge related to the integration of Ranbaxy, which formally became part of Sun in March this year. Sales rose ...
 Economic Times3 weeks ago Sun Pharma sees profit hit in FY16 on Ranbaxy integration  Smart Investor1 month ago India's Sun Pharma expects Ranbaxy costs to hit 2016 revenue  Reuters India1 month ago Sun expects Ranbaxy costs to hit revenue  Hindustan Times1 month ago

Open offer for Zenotech fails to meet target

The committee was formed to look into Sun Pharma's open offer following its acquisition of Ranbaxy Laboratories Ltd. Photo: Hemant Mishra/Mint Mumbai: An open offer by Sun Pharmaceutical Industries Ltd worth Rs. 20.23 crore to acquire a 28.16% ...
 Livemint.com1 month ago

Sun Pharma in process to integrate Ranbaxy, overhauls combined global operations

By Vikas Dandekar MUMBAI: One of Ranbaxy Laboratories' crown jewels is unlikely to enjoy the same pride of place under the new owner. Sun Pharmaceutical Industries may relegate the manufacturing facility at Paonta Sahib in Himachal Pradesh for ...
 Economic Times1 month ago

Sun Pharma cuts projections on integration of Ranbaxy

Sun Pharmaceutical Industries, a Rs. 27,000 crore Indian pharma giant after merging Ranabxy Laboratories, has cut down its sales and profit projections for the year ended March 2015 on account of amalgamation of Ranbaxy Laboratories. The sales are ...
 PharmaBiz1 month ago

Did Ranbaxy give up exclusivity on copycat Provigil?

It's several months into Ranbaxy Laboratories' 180-day exclusivity on generic Provigil. But Ranbaxy hasn't launched its version of the drug. Meanwhile, Par Pharmaceuticals, which shares that exclusivity right, has reaped more than $50 million in ...
 FiercePharma1 month ago Ranbaxy lines up plans for U.S. growth  FiercePharma1 month ago Copycat Lipitor hits in 4 EU countries  FiercePharma1 month ago Lipitor copy powers a surge in Ranbaxy sales, profits  FiercePharma1 month ago

Ranbaxy manufacturing management said to be in Sun's...

Sun Pharmaceutical is expected to start looking at the management of some of the Ranbaxy Laboratories manufacturing sites, with an eye toward flattening out the chain of command, as Sun Managing Director Dilip Shanghvi continues to clean house after ...
 IChainnel1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy laboratories
Get updated on latest news & your favorite topics right in your inbox!
More     Less